Osterholm Update - CIDRAP
Nov 14, 2024 · In "Better Times," Dr. Osterholm and Chris Dall discuss the latest COVID, H5N1, and seasonal influenza data. Dr. Osterholm also answers an ID query on the ideal timing for COVID-19 booster doses and an ID query about Marburg virus transmission.
About CIDRAP | CIDRAP
The Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to ...
Antiviral COVID-19 drug molnupiravir tied to large drop in
3 days ago · When given early, the antiviral drug molnupiravir (Lagevrio) halved the risk of COVID-19 death and reduced all-cause deaths among older adults in the Czech Republic in 2022, findings published yesterday in Open Forum Infectious Diseases suggest. Masaryk University researchers analyzed data from all 74,541 adults with a diagnosis of COVID-19 in the national registry infection treated with ...
Trial supports shorter antibiotic treatment for bloodstream
4 days ago · A randomized controlled trial involving more than 3,600 patients hospitalized with bloodstream infections found that 7 days of antibiotic treatment was noninferior to 14 days, an international team of researchers reported today in the New England Journal of Medicine.. The findings are from the BALANCE (Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness) trial, which was ...
Infectious Disease Topics A-Z - CIDRAP
A comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
Study describes rise in severe Shigella infections in Vancouver
2 days ago · A study in Vancouver found an increase in severe, multidrug-resistant (MDR) shigellosis cases and a shift in patient demographics, researchers reported yesterday in Clinical Infectious Diseases.. For the study, a team of researchers from the University of British Columbia conducted a retrospective review of 163 patients diagnosed as having Shigella sonnei infections from 2015 through 2022.
Novel genomic test shows promise to streamline diagnosis of …
4 days ago · After a decade in development, a new genomic test developed at the University of California–San Francisco (UCSF) promises to rapidly and accurately diagnosis infections caused by almost any pathogen—whether a virus, bacterium, fungus, or parasite. The tool uses a genomic sequencing technique ...
Report: Most fast-food chains aren't making the grade on
3 days ago · A new report suggests most US fast-food and fast-casual restaurant chains have made little progress on efforts to reduce antibiotic use by their meat and poultry suppliers. Of the 20 restaurant chains reviewed in the Serving Up Superbugs report, which grades the chains based on antibiotic use ...
COVID-19 - CIDRAP
Contact Us. CIDRAP - Center for Infectious Disease Research & Policy Research and Innovation Office, University of Minnesota, Minneapolis, MN. Email us
CIDRAP in the News
Oct 27, 2024 Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact paper published in Vaccine is co-authored by Julie Ostrowsky, MSc, et al.. Oct 11, 2024 CIDRAP announces that it has received funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its open-access Coronavirus Vaccines Research and ...